Rights and permissions
About this article
Cite this article
Nebulised bronchodilators should remain the first-line therapy for acute asthma. Inpharma Wkly. 739, 5 (1990). https://doi.org/10.2165/00128413-199007390-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007390-00009